Inventor · disambiguated record
Li Zheng
Also filed as: ZHENG LI · ZHENG LI-MOU
11 granted patents·4 pending applications·16 citations·filing 2002–2025
85Inventor score
Files withHOPE CITY8HUAWEI TECH CO LTD2KING IVAN1SHANGHAI XINGKANG PHARMACEUTIC1THE NAT INSTITUTES OF PHARMACEUTICAL R&D CO LTD1
Top patents by PatentIndex Score
15 records- 0192US9932310B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2017·Granted Apr 3, 2018·5 cites·13 claims
- 0290US10173984B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2018·Granted Jan 8, 2019·5 cites·8 claims
- 0389US11198675B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2020·Granted Dec 14, 2021·2 cites·3 claims
- 0489US10562856B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2018·Granted Feb 18, 2020·3 cites·8 claims
- 0575US11780815B2DNA2 inhibitors for cancer treatmentHOPE CITY·Filed 2021·Granted Oct 10, 2023·0 cites·14 claims
- 0672US11897162B2Piezoresistive sensor material and preparation method and use thereofUNIV ZHEJIANG A&F·Filed 2020·Granted Feb 13, 2024·1 cites·20 claims
- 0762US2023175072A13 flap okazaki fragments and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 0862US2024254277A1Polymer, leveling agent and preparation method thereof, electroplating solution, and electroplating methodHUAWEI TECH CO LTD·Filed 2024·Application pending·0 cites
- 0956US11672812B2Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancerHOPE CITY·Filed 2021·Granted Jun 13, 2023·0 cites·9 claims
- 1046US7927790B2Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processingHOPE CITY·Filed 2006·Granted Apr 19, 2011·0 cites·15 claims
- 1146US2025198036A1Composition and application thereof, and leveling agent and preparation method thereofHUAWEI TECH CO LTD·Filed 2025·Application pending·0 cites
- 1245US7605137B2Combination therapy comprising cloretazineVION PHARMACEUTICALS INC·Filed 2005·Granted Oct 20, 2009·0 cites·15 claims
- 1343US2007298012A1Compositions and Methods for Tumor-Targeted Delivery of Effector MoleculesKING IVAN·Filed 2007·Application pending·0 cites
- 1434US11608334B2Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereofTHE NAT INSTITUTES OF PHARMACEUTICAL R&D CO LTD·Filed 2017·Granted Mar 21, 2023·0 cites·14 claims
- 1530US7015343B2Sulphonated dehydrogenated sylvate, the preparation and useSHANGHAI XINGKANG PHARMACEUTIC·Filed 2002·Granted Mar 21, 2006·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Li Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →